LXEO – lexeo therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Lexeo Therapeutics (NASDAQ:LXEO) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating on the stock.
Gene Therapies for Cardiomyopathies Market Poised for Rapid Expansion During the Forecast Period (2025-2034) with Advancements in AAV and CRISPR Platforms | DelveInsight [Yahoo! Finance]
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
Form EFFECT Lexeo Therapeutics, Inc.
Form 424B3 Lexeo Therapeutics, Inc.
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Townsend Richard Nolan
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Adler Eric
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.